Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what National Institute for Health and Care Excellence-approved interventions are available through the NHS for the treatment of mental health conditions.
The National Institute for Health and Care Excellence (NICE) has published clinical guidelines on a range of mental health topics, such as depression, anxiety and schizophrenia. Clinical guidelines provide guidance on the treatment of patients across the care pathway and each guideline recommends a number of treatments.
Additionally, the following technologies for the treatment of mental health and behavioural conditions are recommended by NICE technology appraisal guidance:
Appraisal Number | Year | Technology | Condition | Categorisation |
TA59 | 2003 | Electroconvulsive therapy | Catatonia/ prolonged or severe manic episode | Optimised1 |
TA098 | 2006 | Atomoxetine | Attention deficit hyperactivity disorder (ADHD) | Recommended |
TA098 | 2006 | Dexamfetamine | Attention deficit hyperactivity disorder (ADHD) | Recommended |
TA098 | 2006 | Methylphenidate | Attention deficit hyperactivity disorder (ADHD) | Recommended |
TA213 | 2011 | Aripiprazole | Schizophrenia in people aged 15-17 years | Recommended |
TA217 | 2011 | Donepezil | Alzheimer's disease (mild to moderate) | Recommended |
TA217 | 2011 | Galantamine | Alzheimer's disease (mild to moderate) | Recommended |
TA217 | 2011 | Rivastigmine | Alzheimer's disease (mild to moderate) | Recommended |
TA217 | 2011 | Memantine | Alzheimer's disease (moderate) | Optimised |
TA217 | 2011 | Memantine | Alzheimer's disease (severe) | Recommended |
TA292 | 2013 | Aripiprazole | Moderate to severe manic episodes in adolescents with bipolar disorder | Recommended |
Source: National Institute for Health and Care Excellence
1 The drug or technology is recommended for a smaller subset of patients than originally stated by the marketing authorisation.
Patients have the right to drugs and treatments that have been recommended by NICE technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate.
Details of all NICE’s guidance on mental health and behavioural conditions can be found at:
www.nice.org.uk/guidancemenu/conditions-and-diseases/mental-health-and-behavioural-conditions